Electromed Inc
smartvest.comWhat Do They Do?
Sells SmartVest airway-clearance systems and related products to patients with impaired lung function, hospitals and health care providers.
10-K for FY2026, filed Aug 25, 2026Electromed, Inc. (“we,” “our,” “us,” “Electromed” or the “Company”) develops, manufactures, markets and sells innovative products that…View ↗
We primarily employ a direct-to-patient and provider model, through which we obtain patient referrals from clinicians, manage insurance…View ↗
Since 2000, we have marketed the SmartVest System and its predecessor products to patients suffering from bronchiectasis, cystic fibrosis…View ↗
We market the Single Patient Use (“SPU”) SmartVest and SmartVest Wrap® to health care providers in the acute care setting. Hospitals issue…View ↗
How Do They Make Money?
Patients’ SmartVest systems are generally paid for by commercial or government insurance programs, through either a one-time payment or capped installments over time. The company counts the sale when the system ships or is delivered, even when the payer’s installments continue afterward.
10-K for FY2026, filed Aug 25, 2026Homecare patients generally will rely on third-party payers, including commercial payers and governmental payers such as Medicare, Medicaid…View ↗
Regardless of the type of transaction, provided criteria for an enforceable contract are met, it is the Company’s long-standing business…View ↗
The Company’s contractually stated transaction prices in the homecare market are generally set by the terms of the contracts negotiated…View ↗
$73.8M
-
10-K for FY2026, filed Aug 25, 2026
$73.8M ↗
Who Are Their Customers?
Patients use SmartVest systems at home, with referrals from clinicians; Electromed handles insurance claims and delivers the system. Hospitals buy products for inpatient use, while a limited number of home medical equipment distributors sell SmartVest systems in the homecare market.
10-K for FY2026, filed Aug 25, 2026We primarily employ a direct-to-patient and provider model, through which we obtain patient referrals from clinicians, manage insurance…View ↗
Since 2000, we have marketed the SmartVest System and its predecessor products to patients suffering from bronchiectasis, cystic fibrosis…View ↗
We market the Single Patient Use (“SPU”) SmartVest and SmartVest Wrap® to health care providers in the acute care setting. Hospitals issue…View ↗
Our direct U.S. sales force works with physicians and clinicians, primarily pulmonologists, in defined territories to help them understand…View ↗
We generate sales interest through multiple channels that include visits to pulmonology clinics and medical centers, participation in…View ↗
Do Revenues Turn Into Profits?
Yes. It kept 15 cents of every revenue dollar as net income in FY2026 and turned 11 cents into free cash flow.
10-K for FY2026, filed Aug 25, 2026
$13.9MView ↗
10-K for FY2026, filed Aug 25, 2026
$11.3MView ↗
10-K for FY2026, filed Aug 25, 2026
$8.4MView ↗
How Are They Changing?
Growing. Revenue grew 77% in 4 years, from $41.7M in FY2022 to $73.8M in FY2026, about 15% a year.
Who Do They Compete With?
Competes with Baxter International, Philips, Tactile Medical, and Insmed
10-K for FY2026, filed Aug 25, 2026The original HFCWO technology was licensed to American Biosystems, Inc. (formerly Hill-Rom Holdings, Inc., now part of Baxter International…View ↗
Loading...
